A detailed history of Rodgers Brothers Inc. transactions in Organon & Co. stock. As of the latest transaction made, Rodgers Brothers Inc. holds 29,321 shares of OGN stock, worth $431,898. This represents 0.08% of its overall portfolio holdings.

Number of Shares
29,321
Previous 30,457 3.73%
Holding current value
$431,898
Previous $630,000 11.11%
% of portfolio
0.08%
Previous 0.09%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$18.65 - $23.03 $21,186 - $26,162
-1,136 Reduced 3.73%
29,321 $560,000
Q2 2024

Aug 14, 2024

SELL
$17.45 - $21.96 $60,534 - $76,179
-3,469 Reduced 10.23%
30,457 $630,000
Q1 2024

May 14, 2024

SELL
$13.78 - $18.8 $45,708 - $62,359
-3,317 Reduced 8.91%
33,926 $637,000
Q4 2023

Feb 13, 2024

SELL
$10.95 - $17.32 $90,381 - $142,959
-8,254 Reduced 18.14%
37,243 $537,000
Q3 2023

Nov 13, 2023

BUY
$16.59 - $23.77 $95,326 - $136,582
5,746 Added 14.45%
45,497 $789,000
Q2 2023

Aug 14, 2023

SELL
$19.27 - $24.63 $807,952 - $1.03 Million
-41,928 Reduced 51.33%
39,751 $827,000
Q1 2023

May 15, 2023

BUY
$21.42 - $32.08 $11,695 - $17,515
546 Added 0.67%
81,679 $1.92 Million
Q4 2022

Feb 14, 2023

SELL
$23.31 - $28.61 $753,029 - $924,246
-32,305 Reduced 28.48%
81,133 $2.27 Million
Q3 2022

Nov 14, 2022

SELL
$23.4 - $34.25 $13,338 - $19,522
-570 Reduced 0.5%
113,438 $2.65 Million
Q2 2022

Aug 15, 2022

SELL
$31.66 - $38.9 $189,960 - $233,400
-6,000 Reduced 5.0%
114,008 $3.85 Million
Q1 2022

May 16, 2022

BUY
$30.45 - $39.36 $876,442 - $1.13 Million
28,783 Added 31.55%
120,008 $4.19 Million
Q4 2021

Feb 14, 2022

SELL
$28.67 - $37.13 $1.26 Million - $1.63 Million
-43,879 Reduced 32.48%
91,225 $2.78 Million
Q3 2021

Nov 15, 2021

BUY
$28.63 - $35.64 $1.73 Million - $2.16 Million
60,594 Added 81.32%
135,104 $4.43 Million
Q2 2021

Aug 16, 2021

BUY
$28.45 - $38.0 $2.12 Million - $2.83 Million
74,510 New
74,510 $2.26 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.75B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Rodgers Brothers Inc. Portfolio

Follow Rodgers Brothers Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rodgers Brothers Inc., based on Form 13F filings with the SEC.

News

Stay updated on Rodgers Brothers Inc. with notifications on news.